OP
WVE icon

ORG Partners’s Wave Life Sciences WVE Stock Holding History

ORG Partners’s Portfolio WVE Stock Details WVE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		$3.4K Buy
200
+100
+100% +$1.02K ﹤0.01% 1338
2025
Q3 		$732 Buy
+100
New +$809 ﹤0.01% 1429

Other funds holding WVE

GP
GSK plc London $602M AUM
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
MC
Maverick Capital Dallas, Texas $11.3B AUM 76.6% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
DGM
Darwin Global Management St. Helier, Jersey $3.76B AUM 342.13% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return
MCM
M28 Capital Management Stamford, Connecticut $47.2M AUM 32.31% 1-Year Est. Return

ORG Partners's WVE Position: Q4 2025 in Review

ORG Partners increased its Wave Life Sciences (WVE) stake by 100% in Q4 2025, buying an estimated $1.02K and bringing the position to 200 shares worth $3.4K. The position accounts for ﹤0.01% of the portfolio, ranked #1338.

ORG Partners first reported a position in WVE in Q3 2025 and has held it in 2 quarters since. 218 funds tracked by Wall St. Rank hold WVE as of Q4 2025.

  • ORG Partners held 200 shares of Wave Life Sciences worth $3.4K as of Q4 2025.
  • ORG Partners bought 100 Wave Life Sciences shares in Q4 2025, an estimated $1.02K.
  • Wave Life Sciences made up ﹤0.01% of ORG Partners's portfolio in Q4 2025, its #1338 holding.
  • ORG Partners first reported a position in Wave Life Sciences in Q3 2025 and has held it in 2 quarters since.
  • 218 funds tracked by Wall St. Rank held Wave Life Sciences as of Q4 2025.

Based on ORG Partners's 13F filing for Q4 2025, filed 14 Jan 2026.